Abbott Abon Multi 9 Drug Doa-194 Drug Testing Kit - Pack of 25 Tests (Doa-194)

The Abbott Abon Multi 9 Drug Doa-194 Drug Testing Kit offers medical professionals a comprehensive solution for the simultaneous detection of nine major drugs of abuse. This advanced kit is designed to provide accurate and rapid insights into patients' substance use, aiding in timely clinical interventions. It is a rapid, qualitative immunoassay designed to detect commonly abused drugs and their metabolites in human urine.

Leveraging advanced immunoassay principles, the kit boasts high sensitivity and specificity for each targeted drug, ensuring reliable results and minimizing false positives and negatives. The Abbott Abon Multi 9 Drug Testing Kit delivers rapid results, typically within 5 minutes, enhancing the efficiency of clinical workflows, particularly in emergency or time-sensitive scenarios.

This multi-panel test is suitable for clinical diagnostics, workplace testing, and forensic applications. It is approved for workplace and forensic use, and intended for professional, in vitro diagnostic use.

Key Features : 

Comprehensive Multi-Drug Panel: The Doa-194 kit features a multi-drug panel that covers nine major substances of abuse, including Amphetamines (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Cocaine (COC), Methamphetamine (mAMP/MET), Methadone (MTD), Opiates (OPI), Phencyclidine (PCP), and Tetrahydrocannabinol (THC).
Urine Sample Type: Designed for the qualitative detection of drugs and their metabolites in human urine specimens.
Optimal Storage Conditions: The kit should be stored between 2–30°C, away from direct sunlight and moisture, to maintain its integrity and performance.
Regulatory Compliance: Approved for workplace and forensic use, and intended for professional, in vitro diagnostic use.